| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP &Chief Accounting Officer | SVP &Controller
1 company
Silva Paul M is a SVP &Chief Accounting Officer at VERTEX PHARMACEUTICALS INC / MA. Recent SEC Form 4 filings include 0 buys and 35 sells.
Estimated insider holdings value: $4.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 13, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Controller | Sale+OE | 859 | $248.72 | $213,649.63 | -0.9% | |
| Apr 6, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Controller | Sale+OE | 4,891 | $255.57 | $1,249,992.87 | -24.7% | |
| Feb 25, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Controller | Sell | 1,080 | $233.45 | $252,127.07 | -1.0% | |
| Feb 18, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Controller | Sell | 1,564 | $243.58 | $380,957.18 | -1.8% | |
| Feb 11, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Controller | Sell | 5,862 | $246.04 | $1,442,300.86 | -5.0% | |
| Feb 6, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Controller | Sale+OE | 466 | $239.32 | $111,523.28 | -0.5% | |
| Feb 3, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Controller | Sale+OE | 2,099 | $231.03 | $484,938.87 | -2.2% | |
| Jan 31, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Controller | Sale+OE | 1,396 | $238.65 | $333,155.40 | -7.3% | |
| Jan 13, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Controller | Sale+OE | 860 | $229.38 | $197,266.80 | -4.6% | |
| Jan 8, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Controller | Sale+OE | 13,750 | $231.89 | $3,188,487.50 | -43.6% |